In stark contrast with previous nanomedicines consuming glucose or blocking amino acid transporter, we, for the first time, developed a coordinative nanocarrier targeting protein catabolism, as a promising strategy for starvation‐based cancer therapy (Figure1). The gene discussed is SLC38A7; the disease is cancer.